Trinity Biotech Statistics Share Statistics Trinity Biotech has 10.39M
shares outstanding. The number of shares has increased by -1.52%
in one year.
Shares Outstanding 10.39M Shares Change (YoY) -1.52% Shares Change (QoQ) -1.52% Owned by Institutions (%) 0.4% Shares Floating 10.02M Failed to Deliver (FTD) Shares 20,060 FTD / Avg. Volume 0.45%
Short Selling Information The latest short interest is 114.44K, so 0.6% of the outstanding
shares have been sold short.
Short Interest 114.44K Short % of Shares Out 0.6% Short % of Float 0.84% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.49 and the forward
PE ratio is -1.04.
Trinity Biotech's PEG ratio is
0.06.
PE Ratio -2.49 Forward PE -1.04 PS Ratio 1.28 Forward PS 0.2 PB Ratio -2.25 P/FCF Ratio -5.54 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Trinity Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.28,
with a Debt / Equity ratio of -2.86.
Current Ratio 1.28 Quick Ratio 0.68 Debt / Equity -2.86 Debt / EBITDA -5.96 Debt / FCF -7.07 Interest Coverage -1.77
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $161.99K Profits Per Employee $-83.66K Employee Count 380 Asset Turnover 0.6 Inventory Turnover 2.07
Taxes Income Tax 486K Effective Tax Rate -1.58%
Stock Price Statistics The stock price has increased by -80.55% in the
last 52 weeks. The beta is 0.96, so Trinity Biotech's
price volatility has been higher than the market average.
Beta 0.96 52-Week Price Change -80.55% 50-Day Moving Average 3.48 200-Day Moving Average 3.65 Relative Strength Index (RSI) 33.47 Average Volume (20 Days) 4,439,701
Income Statement In the last 12 months, Trinity Biotech had revenue of 61.55M
and earned -31.79M
in profits. Earnings per share was -1.8.
Revenue 61.55M Gross Profit 21.44M Operating Income -21.16M Net Income -31.79M EBITDA -16.91M EBIT -18.77M Earnings Per Share (EPS) -1.8
Full Income Statement Balance Sheet The company has 5.17M in cash and 100.76M in
debt, giving a net cash position of -95.6M.
Cash & Cash Equivalents 5.17M Total Debt 100.76M Net Cash -95.6M Retained Earnings -79.12M Total Assets 103.29M Working Capital 9.03M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.19M
and capital expenditures -10.06M, giving a free cash flow of -14.26M.
Operating Cash Flow -4.19M Capital Expenditures -10.06M Free Cash Flow -14.26M FCF Per Share -0.79
Full Cash Flow Statement Margins Gross margin is 34.83%, with operating and profit margins of -34.38% and -51.64%.
Gross Margin 34.83% Operating Margin -34.38% Pretax Margin -49.92% Profit Margin -51.64% EBITDA Margin -27.46% EBIT Margin -34.38% FCF Margin -23.16%
Dividends & Yields TRIB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for TRIB.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 27, 2025. It was a
backward
split with a ratio of 1:5.
Last Split Date Aug 27, 2025 Split Type backward Split Ratio 1:5
Scores Altman Z-Score -0.92 Piotroski F-Score 2
